Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.

Alzheimer’s Research UK renews its flagship Drug Discovery Alliance with significant investment at a pivotal moment for ...

Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.

Scientists have developed a blood test that could predict Alzheimer's symptoms years in advance using p-tau217 protein levels ...

Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the key to stopping the condition in its tracks. It is well established that ...

The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.

Antihypertensives that stimulate angiotensin II receptors are associated with a lower risk for biomarkers of dementia.

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in the brain, they have struggled to understand how these harmful fragments are ...

A new drug for treating Alzheimer’s has only a marginal impact on people with the early stages of the memory loss disease and ...

Scientists have identified prematurely aged astrocytes in the brains of Alzheimer’s patients, particularly those with the APOE4 risk gene. Their findings suggest that cellular senescence in these ...